Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
22
datasets available to search
ShareScore release 0.9.0
Dataset results
22 results for “snakebite”
Datasets for Health care workers' knowledge on identification, management and treatment of snakebite cases in rural Malawi
<p>This is the data for a Health care workers' knowledge on identification, management and treatment of snakebite cases in rural Malawi: a descriptive study.</p>
Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite
ClinicalTrials.gov study NCT04996264. IPD Sharing: NO. Countries: 2. Publications: 37.
Figure 5 in Vulnerability to snakebite envenoming: a global mapping of hotspots
Figure 5: Hotspots of vulnerable populations to medically important venomous snake species Hotspots are defined as people living in areas within the range of one or more medically important venomous snake species,and more than 3 h away from major urban centreswith Healthcare Access and Quality Index deciles of 1–3. (A) Pixel-level vulnerability surface (ie,vulnerability to all species of medically important snakes).(B) Aggregated second administrative level vulnerability to all species of medically important venomous snakes,as measured by the absolute number of people.(C) Aggregated second administrative level vulnerability to only those species for which no effective therapy is currently listed by WHO,as measured by the absolute number of people.
Figure 3 in Vulnerability to snakebite envenoming: a global mapping of hotspots
Figure 3: Average traveltime to nearest major city for populations living within snake ranges The light grey areas represent locations withoutthe presence of medically important venomous snake species.
Figure 4 in Vulnerability to snakebite envenoming: a global mapping of hotspots
Figure 4: Proportion of populations living within range of snake species by each HAQ Index decile (A) Populations living within the range of one or more medically important venomous snake species (either category one or two).(B) Populations living within the range of one or more medically important venomous snake species (either category one or two),for which no effective therapy is listed.HAQ=Healthcare Access and Quality.
Figure2 in Vulnerability to snakebite envenoming: a global mapping of hotspots
Figure2: Ranges of venomous snake species and number of medically important venomous snake species per 5 × 5 km location for which no effective therapy is currently listed byWHO (A)Counts range from low (n=1) to high (n=13).The light grey areas represent locations where no medically important venomous snake species are present.(B) Counts range from low (n=1) to high (n=7).The light grey areas represent locations where snake species present have effective therapies listed by WHO,and the dark grey areas represent locations where no medically important venomous snake species are present.
Figure 1 in Vulnerability to snakebite envenoming: a global mapping of hotspots
Figure 1: Conceptual overview of vulnerability to snakebite envenoming (A) Vulnerability can be considered as the intersection of populations who live within the range of venomous snakes that have no antivenoms available, cannot easily access health care,and have poor quality health care in delivery of antivenoms or ensuring necessary stocks.The intersection of all three defines the most vulnerable populations.(B)These factors vary in space.By overlaying these features,the most vulnerable populations can be identified spatially (represented here by the boxes outlined in black).
Waveform Analysis In Snakebite Victims With Hematotoxicity
ClinicalTrials.gov study NCT03859154. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Hemostatic Variables In Snakebite Study
ClinicalTrials.gov study NCT04520282. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Safety and Effectiveness of PANAF-Premium TM Snake Venom Antiserum As Standard Treatment for Snakebites
ClinicalTrials.gov study NCT06615960. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO)
ClinicalTrials.gov study NCT05717062. IPD Sharing: NO. Countries: 1. Publications: 0.
Mapping Snakebite Risk in Ghana and Rwanda
ClinicalTrials.gov study NCT06808789. IPD Sharing: UNDECIDED. Countries: 0. Publications: 21.
Evaluation of Snakebite Cases in Assiut Governorate, Egypt (Prospective Study)
ClinicalTrials.gov study NCT06703645. IPD Sharing: Not stated. Countries: 0. Publications: 9.
Molecular dissection of cobra venom highlights heparinoids as an effective snakebite antidote
GEO Series GSE262798. Homo sapiens. 8 samples. Type: Other.
Incidence of Snakebite Associated Thrombotic Microangiopathy & Role of Peripheral Blood Smear as a Predictor of Clinical Outcome
ClinicalTrials.gov study NCT04845022. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Snakebite Prevention and First Aid Through Community Engagement
ClinicalTrials.gov study NCT05872373. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predictive Modeling of Necrotizing Skin Infections in Snakebite Patients
ClinicalTrials.gov study NCT06622343. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective Observational Study to Determine the Predictive Accuracy of Snakebite Severity Score (SSS) in Identifying Syndrome-Specific Core Outcome Parameters Amongst Envenomated Patients Presentin
ClinicalTrials.gov study NCT07079137. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Mapping Snakebite Risk in Kenya and Eswatini
ClinicalTrials.gov study NCT06124872. IPD Sharing: YES. Countries: 1. Publications: 0.
Study Comparing Modified Lee White Clotting Time Against Twenty Minute Whole Blood Clotting Test in Snakebite Victims
ClinicalTrials.gov study NCT03890016. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.